Impact of mis-specification of the treatment model on estimates from a marginal structural model.
about
Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherenceHigh-dimensional propensity score adjustment in studies of treatment effects using health care claims dataTime-modified confounding.Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.Estimating ethnic differences in self-reported new use of antidepressant medications: results from the Multi-Ethnic Study of Atherosclerosis.Contours of a causal feedback mechanism between adaptive personality and psychosocial function in patients with personality disorders: a secondary analysis from a randomized clinical trial.Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.Lung cancer survival with herbal medicine and vitamins in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.An information criterion for marginal structural models.Improving propensity score estimators' robustness to model misspecification using super learner.Statistical power in parallel group point exposure studies with time-to-event outcomes: an empirical comparison of the performance of randomized controlled trials and the inverse probability of treatment weighting (IPTW) approachThe Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models.Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication useThe challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartan.Estimating inverse probability weights using super learner when weight-model specification is unknown in a marginal structural Cox model context.Comparative effectiveness of mycophenolate mofetil for the treatment of childhood-onset proliferative lupus nephritis.Impact of sedation and analgesia during noninvasive positive pressure ventilation on outcome: a marginal structural model causal analysis.Marginal Structural Models: unbiased estimation for longitudinal studies.The Balance Super Learner: A robust adaptation of the Super Learner to improve estimation of the average treatment effect in the treated based on propensity score matching.simcausal R Package: Conducting Transparent and Reproducible Simulation Studies of Causal Effect Estimation with Complex Longitudinal Data.Effect Estimation in Point-Exposure Studies with Binary Outcomes and High-Dimensional Covariate Data - A Comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting.Variable Selection for Confounder Control, Flexible Modeling and Collaborative Targeted Minimum Loss-Based Estimation in Causal Inference.The Effect of Error-in-Confounders on the Estimation of the Causal Parameter When Using Marginal Structural Models and Inverse Probability-of-Treatment Weights: A Simulation StudyThe positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding
P2860
Q24658518-658FA344-D9A1-443E-B876-856A6A893005Q33457966-752A9D8E-663D-4A20-BEB0-44507106478FQ33566613-A553050A-DC0E-4C55-ABA7-C641183862D4Q33707284-20BE83C4-D738-4DBB-B789-B25C04A168F9Q33748358-F63245DB-B827-4BC7-89A8-AEDC04C09678Q33768190-E60C65A3-6955-4930-B11E-E874939445C9Q33844625-CC7516E9-B8FE-465A-87BB-2187A35C0074Q33985493-A25E9349-287F-4B40-AF15-0D6F58E86BC5Q34266978-179EEF12-7861-43FF-9D7D-EF418011ABB4Q35152699-E41CBFF8-E484-4DAA-8DED-604C02BE6374Q35809586-E66A7164-24A4-462B-9EC9-0C3917795B6FQ36089346-99B17251-214F-428F-B35A-19AD1D63DD1DQ37613246-20825D88-3EEE-4526-8E46-91F1D6FAFE0EQ37731789-2D57C9EE-A2C9-4102-A7B4-34365DFEBC54Q38951608-C1D8359E-DA4E-4FAC-90DA-5CD2621A3E33Q38969469-45438859-382A-4A81-AE92-EB9CAE6ADEA5Q40942926-04D23877-89E2-4CB0-BF9B-3BCEEED08B95Q43527732-66A719F1-193D-4352-8F93-BE6929DFC0B4Q45952590-EED5CE64-F534-46FB-A516-BD95DCDB8162Q45991120-A9E83D30-332C-4195-BA50-481CA8B3A506Q53225537-A23649F7-211E-4138-AEB8-DF6B6D774AE6Q55084096-D4B865BA-E378-4351-83D9-5AC7EA3DCB22Q57234283-6AC0CF78-C159-457B-9FF9-7CA1525BE53DQ57234340-03F71CB2-446E-45E1-9F0A-3DD6BB60FE39
P2860
Impact of mis-specification of the treatment model on estimates from a marginal structural model.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Impact of mis-specification of ...... m a marginal structural model.
@en
Impact of mis-specification of ...... m a marginal structural model.
@nl
type
label
Impact of mis-specification of ...... m a marginal structural model.
@en
Impact of mis-specification of ...... m a marginal structural model.
@nl
prefLabel
Impact of mis-specification of ...... m a marginal structural model.
@en
Impact of mis-specification of ...... m a marginal structural model.
@nl
P356
P1476
Impact of mis-specification of ...... m a marginal structural model.
@en
P2093
Geneviève Lefebvre
P304
P356
10.1002/SIM.3200
P407
P577
2008-08-01T00:00:00Z